Details for New Drug Application (NDA): 040765
✉ Email this page to a colleague
NDA 040765 describes EXTENDED PHENYTOIN SODIUM, which is a drug marketed by Amneal Pharms Ny, Ani Pharms, Lupin Ltd, Mylan, Sun Pharm Inds, Sun Pharm Inds (in), Taro, Unichem, Wockhardt, and Wockhardt Usa, and is included in eleven NDAs. It is available from eleven suppliers. Additional details are available on the EXTENDED PHENYTOIN SODIUM profile page.
The generic ingredient in EXTENDED PHENYTOIN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
The generic ingredient in EXTENDED PHENYTOIN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
Summary for 040765
| Tradename: | EXTENDED PHENYTOIN SODIUM |
| Applicant: | Amneal Pharms Ny |
| Ingredient: | phenytoin sodium |
| Patents: | 0 |
Pharmacology for NDA: 040765
Suppliers and Packaging for NDA: 040765
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| EXTENDED PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 040765 | ANDA | Amneal Pharmaceuticals LLC | 65162-212 | 65162-212-03 | 30 CAPSULE in 1 BOTTLE (65162-212-03) |
| EXTENDED PHENYTOIN SODIUM | phenytoin sodium | CAPSULE;ORAL | 040765 | ANDA | Amneal Pharmaceuticals LLC | 65162-212 | 65162-212-10 | 100 CAPSULE in 1 BOTTLE (65162-212-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG EXTENDED | ||||
| Approval Date: | Nov 12, 2008 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
